{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:59:14Z","timestamp":1791968354990,"version":"4.3.4"},"reference-count":174,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1210\/er.2018-00011","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T16:18:16Z","timestamp":1539188296000},"page":"97-117","source":"Crossref","is-referenced-by-count":282,"title":["Endocrinology of Transgender Medicine"],"prefix":"10.1210","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0457-9673","authenticated-orcid":false,"given":"Guy","family":"T\u2019Sjoen","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Ghent University Hospital, Ghent, Belgium"},{"name":"Center for Sexology and Gender, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3805-0180","authenticated-orcid":false,"given":"Jon","family":"Arcelus","sequence":"additional","affiliation":[{"name":"Institute of Mental Health, Jubilee Campus, University of Nottingham, Nottingham, United Kingdom"},{"name":"Nottingham Centre for Transgender Health, Nottingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Gooren","sequence":"additional","affiliation":[{"name":"University Hospital, Vrije Universiteit of Amsterdam, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T","family":"Klink","sequence":"additional","affiliation":[{"name":"ZNA Queen Paola Children\u2019s Hospital, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4021-5853","authenticated-orcid":false,"given":"Vin","family":"Tangpricha","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, version 7","volume":"13","author":"Coleman","year":"2012","journal-title":"Int J Transgenderism"},{"key":"key\n\t\t\t\t2019011223580541100_B2","first-page":"1","volume-title":"The Transgender Handbook: A Guide for Transgender People, Their Families and Professionals","author":"Arcelus","year":"2017","edition":"1st ed."},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/09540261.2015.1106446","article-title":"Non-binary or genderqueer genders","volume":"28","author":"Richards","year":"2016","journal-title":"Int Rev Psychiatry"},{"key":"key\n\t\t\t\t2019011223580541100_B4","first-page":"274","article-title":"Psychopathia transsexualis","volume":"16","author":"Cauldwell","year":"1949","journal-title":"Sexology"},{"key":"key\n\t\t\t\t2019011223580541100_B5","author":"World Health Organization"},{"issue":"10","key":"key\n\t\t\t\t2019011223580541100_B6","doi-asserted-by":"crossref","first-page":"e0160066","DOI":"10.1371\/journal.pone.0160066","article-title":"Gender incongruence of adolescence and adulthood: acceptability and clinical utility of the World Health Organization\u2019s proposed ICD-11 criteria","volume":"11","author":"Beek","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.eurpsy.2015.04.005","article-title":"Systematic review and meta-analysis of prevalence studies in transsexualism","volume":"30","author":"Arcelus","year":"2015","journal-title":"Eur Psychiatry"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3999(98)00085-3","article-title":"Transsexualism: a review of etiology, diagnosis and treatment","volume":"46","author":"Cohen-Kettenis","year":"1999","journal-title":"J Psychosom Res"},{"key":"key\n\t\t\t\t2019011223580541100_B9","author":"American Psychiatric Assocation"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B10","doi-asserted-by":"crossref","first-page":"e0168522","DOI":"10.1371\/journal.pone.0168522","article-title":"Gender incongruence of childhood: clinical utility and stakeholder agreement with the World Health Organization\u2019s proposed ICD-11 criteria","volume":"12","author":"Beek","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019011223580541100_B11","author":"European Parliament"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00005053-196811000-00003","article-title":"The current status of the change of sex operation","volume":"147","author":"Pauly","year":"1968","journal-title":"J Nerv Ment Dis"},{"issue":"05","key":"key\n\t\t\t\t2019011223580541100_B13","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1192\/bjp.152.5.638","article-title":"Prevalence of transsexualism in the Netherlands","volume":"152","author":"Eklund","year":"1988","journal-title":"Br J Psychiatry"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1600-0447.1996.tb10645.x","article-title":"Incidence and sex ratio of transsexualism in Sweden","volume":"93","author":"Land\u00e9n","year":"1996","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF02437583","article-title":"Transsexualism in Germany: empirical data on epidemiology and application of the German Transsexuals\u2019 Act during its first ten years","volume":"25","author":"Weitze","year":"1996","journal-title":"Arch Sex Behav"},{"issue":"8","key":"key\n\t\t\t\t2019011223580541100_B16","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s10508-014-0300-8","article-title":"An analysis of all applications for sex reassignment surgery in Sweden, 1960\u20132010: prevalence, incidence, and regrets","volume":"43","author":"Dhejne","year":"2014","journal-title":"Arch Sex Behav"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2105\/AJPH.2011.300315","article-title":"Transgender health in Massachusetts: results from a household probability sample of adults","volume":"102","author":"Conron","year":"2012","journal-title":"Am J Public Health"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10508-013-0140-y","article-title":"Gender identities and gender dysphoria in the Netherlands","volume":"43","author":"Kuyper","year":"2014","journal-title":"Arch Sex Behav"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B19","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s10508-014-0452-6","article-title":"Prevalence of gender nonconformity in Flanders, Belgium","volume":"44","author":"Van Caenegem","year":"2015","journal-title":"Arch Sex Behav"},{"key":"key\n\t\t\t\t2019011223580541100_B20","first-page":"13","volume-title":"The Transgender Handbook: A Guide for Transgender People, Their Families and Professionals","author":"Arcelus","year":"2017"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/09540261.2015.1115753","article-title":"Mental health and gender dysphoria: a review of the literature","volume":"28","author":"Dhejne","year":"2016","journal-title":"Int Rev Psychiatry"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1192\/bjp.bp.112.121954","article-title":"Psychiatric characteristics in transsexual individuals: multicentre study in four European countries","volume":"204","author":"Heylens","year":"2014","journal-title":"Br J Psychiatry"},{"issue":"10","key":"key\n\t\t\t\t2019011223580541100_B23","doi-asserted-by":"crossref","first-page":"e78469","DOI":"10.1371\/journal.pone.0078469","article-title":"Psychopathological profiles in transsexuals and the challenge of their special status among the sexes","volume":"8","author":"Auer","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"key\n\t\t\t\t2019011223580541100_B24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10508-007-9307-8","article-title":"Sociodemographic, clinical, and psychiatric characteristics of transsexuals from Spain","volume":"38","author":"G\u00f3mez-Gil","year":"2009","journal-title":"Arch Sex Behav"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/15532739.2016.1258352","article-title":"Transgender and anxiety: a comparative study between transgender people and the general population","volume":"18","author":"Bouman","year":"2016","journal-title":"Int J Transgenderism"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15532739.2016.1258353","article-title":"Prevalence of anxiety symptoms and disorders in the transgender population: a systematic review of the literature","volume":"18","author":"Millet","year":"2016","journal-title":"Int J Transgenderism"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/jsm.12711","article-title":"Non-suicidal self-injury in trans people: associations with psychological symptoms, victimization, interpersonal functioning, and perceived social support","volume":"12","author":"Claes","year":"2015","journal-title":"J Sex Med"},{"issue":"3","key":"key\n\t\t\t\t2019011223580541100_B28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jsxm.2016.01.003","article-title":"Risk factors for non-suicidal self-injury among trans youth","volume":"13","author":"Arcelus","year":"2016","journal-title":"J Sex Med"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/09540261.2015.1073143","article-title":"Non-suicidal self-injury and suicidality in trans people: a systematic review of the literature","volume":"28","author":"Marshall","year":"2016","journal-title":"Int Rev Psychiatry"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B30","doi-asserted-by":"crossref","first-page":"e16885","DOI":"10.1371\/journal.pone.0016885","article-title":"Long-term follow-up of transsexual persons undergoing sex reassignment surgery: cohort study in Sweden","volume":"6","author":"Dhejne","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B31","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.psyneuen.2011.08.010","article-title":"Hormone-treated transsexuals report less social distress, anxiety and depression","volume":"37","author":"G\u00f3mez-Gil","year":"2012","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1440-1819.2010.02118.x","article-title":"Psychiatric comorbidity among patients with gender identity disorder","volume":"64","author":"Hoshiai","year":"2010","journal-title":"Psychiatry Clin Neurosci"},{"issue":"12","key":"key\n\t\t\t\t2019011223580541100_B33","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/jclp.22209","article-title":"Interpersonal functioning among treatment-seeking trans individuals","volume":"71","author":"Davey","year":"2015","journal-title":"J Clin Psychol"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B34","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s10508-009-9551-1","article-title":"A five-year follow-up study of Swedish adults with gender identity disorder","volume":"39","author":"Johansson","year":"2010","journal-title":"Arch Sex Behav"},{"key":"key\n\t\t\t\t2019011223580541100_B35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.psyneuen.2013.09.029","article-title":"Transsexual patients\u2019 psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study","volume":"39","author":"Colizzi","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/jsm.12363","article-title":"Effects of different steps in gender reassignment therapy on psychopathology: a prospective study of persons with a gender identity disorder","volume":"11","author":"Heylens","year":"2014","journal-title":"J Sex Med"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B37","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s10508-014-0453-5","article-title":"Long-term follow-up of adults with gender identity disorder","volume":"44","author":"Ruppin","year":"2015","journal-title":"Arch Sex Behav"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1300\/J056v05n04_05","article-title":"Regrets after sex reassignment surgery","volume":"5","author":"Pf\u00e4fflin","year":"1992","journal-title":"J Psychol Human Sex"},{"key":"key\n\t\t\t\t2019011223580541100_B39","article-title":"Gender role reversal among postoperative transsexuals","volume":"2","author":"Kuiper","year":"1998","journal-title":"Int J Transgenderism"},{"issue":"11","key":"key\n\t\t\t\t2019011223580541100_B40","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-8587(16)30319-9","article-title":"Oestrogen and anti-androgen therapy for transgender women","volume":"5","author":"Tangpricha","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2265.2009.03625.x","article-title":"Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes","volume":"72","author":"Murad","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"key\n\t\t\t\t2019011223580541100_B43","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1210\/jc.2016-1276","article-title":"Cross-sex hormone treatment and psychobiological changes in transsexual persons: two-year follow-up data","volume":"101","author":"Fisher","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"key\n\t\t\t\t2019011223580541100_B44","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jsm.12571","article-title":"Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B45","first-page":"55","article-title":"Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals","volume":"2","author":"Weinand","year":"2015","journal-title":"J Clin Transl Endocrinol"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.psc.2016.10.011","article-title":"Affirmative psychological testing and neurocognitive assessment with transgender adults","volume":"40","author":"Keo-Meier","year":"2017","journal-title":"Psychiatr Clin North Am"},{"issue":"11","key":"key\n\t\t\t\t2019011223580541100_B47","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/journalofethics.2016.18.11.pfor1-1611","article-title":"Affirmative and responsible health care for people with nonconforming gender identities and expressions","volume":"18","author":"Eckstrand","year":"2016","journal-title":"AMA J Ethics"},{"issue":"11","key":"key\n\t\t\t\t2019011223580541100_B48","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/journalofethics.2016.18.11.sect1-1611","article-title":"Informed consent in the medical care of transgender and gender-nonconforming patients","volume":"18","author":"Cavanaugh","year":"2016","journal-title":"AMA J Ethics"},{"issue":"3","key":"key\n\t\t\t\t2019011223580541100_B49","doi-asserted-by":"crossref","first-page":"339.e19","DOI":"10.1016\/j.amjmed.2015.10.014","article-title":"Lifetime risk of venous thromboembolism in two cohort studies","volume":"129","author":"Bell","year":"2016","journal-title":"Am J Med"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B50","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.4158\/EP13103.CR","article-title":"Risks and benefits of estrogen therapy for a male-to-female transsexual with a prothrombin gene mutation","volume":"19","author":"Laidlaw","year":"2013","journal-title":"Endocr Pract"},{"issue":"7","key":"key\n\t\t\t\t2019011223580541100_B51","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/and.12150","article-title":"Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review","volume":"46","author":"Asscheman","year":"2014","journal-title":"Andrologia"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B52","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jsxm.2016.03.371","article-title":"A European network for the investigation of gender incongruence: endocrine part","volume":"13","author":"Dekker","year":"2016","journal-title":"J Sex Med"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B53","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1089\/lgbt.2016.0190","article-title":"Transient elevated serum prolactin in trans women is caused by cyproterone acetate treatment","volume":"4","author":"Defreyne","year":"2017","journal-title":"LGBT Health"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B54","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/jbmr.3102","article-title":"Bone mineral density increases in trans persons after 1 year of hormonal treatment: a multicenter prospective observational study","volume":"32","author":"Wiepjes","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B55","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0030-1255074","article-title":"Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist","volume":"119","author":"Mueller","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"12","key":"key\n\t\t\t\t2019011223580541100_B56","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1210\/jc.2012-2030","article-title":"Predictive markers for mammoplasty and a comparison of side effect profiles in transwomen taking various hormonal regimens","volume":"97","author":"Seal","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B57","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4158\/EP12170.OR","article-title":"Endocrine treatment of transsexual persons: extensive personal experience","volume":"19","author":"Leinung","year":"2013","journal-title":"Endocr Pract"},{"issue":"3","key":"key\n\t\t\t\t2019011223580541100_B58","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AOG.0000000000000692","article-title":"Effects of cross-sex hormone treatment on transgender women and men","volume":"125","author":"Deutsch","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01579291","article-title":"Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism","volume":"18","author":"Prior","year":"1989","journal-title":"Arch Sex Behav"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B60","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/cen.13050","article-title":"Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness","volume":"85","author":"Gava","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"key\n\t\t\t\t2019011223580541100_B61","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2014part 2","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B62","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/09513590.2017.1395839","article-title":"Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review","volume":"34","author":"Mancini","year":"2018","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B63","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1365-2125.2011.04031.x","article-title":"Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study","volume":"72","author":"Gil","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"key\n\t\t\t\t2019011223580541100_B64","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3174\/ajnr.A1978","article-title":"Abrupt regression of a meningioma after discontinuation of cyproterone treatment","volume":"31","author":"Gon\u00e7alves","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B65","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S2213-8587(17)30068-2","article-title":"Transgender hormone therapy: understanding international variation in practice","volume":"5","author":"Mamoojee","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4158\/EP-2017-0116","article-title":"Testosterone levels achieved by medically treated transgender women in a United States endocrinology clinic cohort","volume":"24","author":"Liang","year":"2018","journal-title":"Endocr Pract"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B67","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/jsm.12487","article-title":"Clinical review: breast development in trans women receiving cross-sex hormones","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B68","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B69","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.thromres.2010.08.010","article-title":"Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study","volume":"126","author":"Barsoum","year":"2010","journal-title":"Thromb Res"},{"issue":"7","key":"key\n\t\t\t\t2019011223580541100_B70","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/ced.13184","article-title":"Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients","volume":"42","author":"Moreno-Arrones","year":"2017","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B71","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/trgh.2016.0022","article-title":"Scalp hair regrowth in hormone-treated transgender woman","volume":"1","author":"Stevenson","year":"2016","journal-title":"Transgend Health"},{"issue":"3","key":"key\n\t\t\t\t2019011223580541100_B72","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/MED.0000000000000158","article-title":"Safety concerns regarding 5\u03b1 reductase inhibitors for the treatment of androgenetic alopecia","volume":"22","author":"Irwig","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"12","key":"key\n\t\t\t\t2019011223580541100_B73","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1210\/jc.2016-2726","article-title":"Characteristics of men who report persistent sexual symptoms after finasteride use for hair loss","volume":"101","author":"Basaria","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B74","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01542220","article-title":"Physical and hormonal evaluation of transsexual patients: a longitudinal study","volume":"15","author":"Meyer","year":"1986","journal-title":"Arch Sex Behav"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B75","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2017-01927","article-title":"Breast development in transwomen after 1 year of cross-sex hormone therapy: results of a prospective multicenter study","volume":"103","author":"de Blok","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B76","doi-asserted-by":"crossref","first-page":"e12660","DOI":"10.1111\/and.12660","article-title":"Cross-sex hormone therapy in transgender persons affects total body weight, body fat and lean body mass: a meta-analysis","volume":"49","author":"Klaver","year":"2017","journal-title":"Andrologia"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B77","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.endonu.2015.02.001","article-title":"Effect of cross-sex hormone treatment on cardiovascular risk factors in transsexual individuals. Experience in a specialized unit in Catalonia","volume":"62","author":"Quir\u00f3s","year":"2015","journal-title":"Endocrinol Nutr"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B78","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/EJE-17-0496","article-title":"Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study","volume":"178","author":"Klaver","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B79","doi-asserted-by":"crossref","first-page":"e20163173","DOI":"10.1542\/peds.2016-3173","article-title":"Cross-sex hormones and metabolic parameters in adolescents with gender dysphoria","volume":"139","author":"Jarin","year":"2017","journal-title":"Pediatrics"},{"issue":"12","key":"key\n\t\t\t\t2019011223580541100_B80","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1002\/lary.26716","article-title":"Self-perception of voice in transgender persons during cross-sex hormone therapy","volume":"127","author":"Bultynck","year":"2017","journal-title":"Laryngoscope"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B81","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/lary.26110","article-title":"Perceptual analysis of the male-to-female transgender voice after glottoplasty\u2014the telephone test","volume":"127","author":"Meister","year":"2017","journal-title":"Laryngoscope"},{"issue":"3","key":"key\n\t\t\t\t2019011223580541100_B82","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15532739.2015.1075931","article-title":"Voice and communication change for gender nonconforming individuals: giving voice to the person inside","volume":"16","author":"Davies","year":"2015","journal-title":"Int J Transgenderism"},{"issue":"11","key":"key\n\t\t\t\t2019011223580541100_B83","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1002\/lary.26692","article-title":"Laryngeal surgical treatment in transgender women: a systematic review and meta-analysis","volume":"127","author":"Schwarz","year":"2017","journal-title":"Laryngoscope"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B84","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaad.2015.10.013","article-title":"A potential role for the dermatologist in the physical transformation of transgender people: a survey of attitudes and practices within the transgender community","volume":"74","author":"Ginsberg","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B85","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-13-0493","article-title":"Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study","volume":"169","author":"Wierckx","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"key\n\t\t\t\t2019011223580541100_B86","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1210\/jc.2017-01643","article-title":"Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis","volume":"102","author":"Maraka","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B87","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.fertnstert.2008.12.017","article-title":"Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy","volume":"93","author":"Ott","year":"2010","journal-title":"Fertil Steril"},{"issue":"13","key":"key\n\t\t\t\t2019011223580541100_B88","doi-asserted-by":"crossref","first-page":"E502","DOI":"10.1503\/cmaj.160408","article-title":"Deep vein thrombosis in a transgender woman","volume":"189","author":"Chan","year":"2017","journal-title":"CMAJ"},{"issue":"9","key":"key\n\t\t\t\t2019011223580541100_B89","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199808273390905","article-title":"Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency","volume":"339","author":"Bilezikian","year":"1998","journal-title":"N Engl J Med"},{"issue":"16","key":"key\n\t\t\t\t2019011223580541100_B90","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJM199410203311604","article-title":"Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man","volume":"331","author":"Smith","year":"1994","journal-title":"N Engl J Med"},{"issue":"11","key":"key\n\t\t\t\t2019011223580541100_B91","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1210\/jc.2017-01642","article-title":"Effect of sex steroids on the bone health of transgender individuals: a systematic review and meta-analysis","volume":"102","author":"Singh-Ospina","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B92","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/EJE-14-0586","article-title":"Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI)","volume":"172","author":"Van Caenegem","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"key\n\t\t\t\t2019011223580541100_B93","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1111\/jsm.12319","article-title":"Breast cancer development in transsexual subjects receiving cross-sex hormone treatment","volume":"10","author":"Gooren","year":"2013","journal-title":"J Sex Med"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B94","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10549-014-3213-2","article-title":"Incidence of breast cancer in a cohort of 5,135 transgender veterans","volume":"149","author":"Brown","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B95","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/lgbt.2014.0123","article-title":"Breast cancer in transgender veterans: a ten-case series","volume":"2","author":"Brown","year":"2015","journal-title":"LGBT Health"},{"issue":"8","key":"key\n\t\t\t\t2019011223580541100_B96","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.annepidem.2017.07.007","article-title":"Cohort study of cancer risk among insured transgender people","volume":"27","author":"Silverberg","year":"2017","journal-title":"Ann Epidemiol"},{"key":"key\n\t\t\t\t2019011223580541100_B97","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.urology.2017.08.032","article-title":"Prostate cancer in transgender women: incidence, etiopathogenesis, and management challenges","volume":"110","author":"Deebel","year":"2017","journal-title":"Urology"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B98","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.med.0000436184.42554.b7","article-title":"Transgenderism and reproduction","volume":"20","author":"T\u02bcSjoen","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B99","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jadohealth.2016.12.012","article-title":"Low fertility preservation utilization among transgender youth","volume":"61","author":"Nahata","year":"2017","journal-title":"J Adolesc Health"},{"issue":"11","key":"key\n\t\t\t\t2019011223580541100_B100","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jsxm.2016.09.012","article-title":"Differential effects of cyproterone acetate vs spironolactone on serum high-density lipoprotein and prolactin concentrations in the hormonal treatment of transgender women","volume":"13","author":"Fung","year":"2016","journal-title":"J Sex Med"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B101","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jsm.12366","article-title":"Short- and long-term clinical skin effects of testosterone treatment in trans men","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B102","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"key\n\t\t\t\t2019011223580541100_B103","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1210\/jc.2017-00359","article-title":"Subcutaneous injection of testosterone is an effective and preferred alternative to intramuscular injection: demonstration in female-to-male transgender patients","volume":"102","author":"Spratt","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t2019011223580541100_B104","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/lgbt.2014.0018","article-title":"Subcutaneous testosterone: an effective delivery mechanism for masculinizing young transgender men","volume":"1","author":"Olson","year":"2014","journal-title":"LGBT Health"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B105","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/EJE-09-0412","article-title":"Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals","volume":"161","author":"Jacobeit","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"key\n\t\t\t\t2019011223580541100_B106","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1111\/jsm.12698","article-title":"Effects of three different testosterone formulations in female-to-male transsexual persons","volume":"11","author":"Pelusi","year":"2014","journal-title":"J Sex Med"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B107","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1210\/jc.2007-1809","article-title":"Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience","volume":"93","author":"Gooren","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t2019011223580541100_B108","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MED.0000000000000064","article-title":"Management of female-to-male transgender persons: medical and surgical management, life expectancy","volume":"21","author":"Gooren","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B109","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/15532739.2015.1080649","article-title":"Retrospective study of the management of childhood and adolescent gender identity disorder using medroxyprogesterone acetate","volume":"16","author":"Lynch","year":"2015","journal-title":"Int J Transgenderism"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-8587(16)00036-X","article-title":"Testosterone therapy for transgender men","volume":"5","author":"Irwig","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"13","key":"key\n\t\t\t\t2019011223580541100_B111","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJMcp1008161","article-title":"Clinical practice. Care of transsexual persons","volume":"364","author":"Gooren","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B112","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/cen.12753","article-title":"Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen","volume":"83","author":"Meriggiola","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B113","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1089\/trgh.2017.0023","article-title":"The response of the menstrual cycle to initiation of hormonal therapy in transgender men","volume":"2","author":"Ahmad","year":"2017","journal-title":"Transgend Health"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B114","doi-asserted-by":"crossref","first-page":"809","DOI":"10.4103\/1008-682X.133972","article-title":"Should cross-sex hormone treatment of transsexual subjects vary with ethnic group","volume":"16","author":"Gooren","year":"2014","journal-title":"Asian J Androl"},{"issue":"8","key":"key\n\t\t\t\t2019011223580541100_B115","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/jsm.12563","article-title":"Conjectures concerning cross-sex hormone treatment of aging transsexual persons","volume":"11","author":"Gooren","year":"2014","journal-title":"J Sex Med"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B116","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/andr.12382","article-title":"Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review","volume":"5","author":"Velho","year":"2017","journal-title":"Andrology"},{"issue":"4\u20135","key":"key\n\t\t\t\t2019011223580541100_B117","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.physbeh.2007.11.033","article-title":"The relationship between testosterone and vocal frequencies in human males","volume":"93","author":"Evans","year":"2008","journal-title":"Physiol Behav"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B118","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/lary.24480","article-title":"Voice in female-to-male transsexual persons after long-term androgen therapy","volume":"124","author":"Cosyns","year":"2014","journal-title":"Laryngoscope"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B119","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s10508-017-1095-1","article-title":"Masculine voices predict well-being in female-to-male transgender individuals","volume":"47","author":"Watt","year":"2018","journal-title":"Arch Sex Behav"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/andr.12278","article-title":"Effects of testosterone on the transgender male voice","volume":"5","author":"Irwig","year":"2017","journal-title":"Andrology"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B121","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/1460-6984.12319","article-title":"Associations between the Transsexual Voice Questionnaire (TVQMtF) and self-report of voice femininity and acoustic voice measures","volume":"52","author":"Dacakis","year":"2017","journal-title":"Int J Lang Commun Disord"},{"issue":"8","key":"key\n\t\t\t\t2019011223580541100_B122","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1210\/jcem.85.8.6710","article-title":"Effects of sex steroid deprivation\/administration on hair growth and skin sebum production in transsexual males and females","volume":"85","author":"Giltay","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key\n\t\t\t\t2019011223580541100_B123","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/j.1743-6109.2010.01912.x","article-title":"Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals","volume":"7","author":"Mueller","year":"2010","journal-title":"J Sex Med"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B124","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1677\/joe.0.1800107","article-title":"Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals","volume":"180","author":"Giltay","year":"2004","journal-title":"J Endocrinol"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B125","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1530\/EJE-14-0011","article-title":"Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern","volume":"170","author":"Gooren","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B126","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/and.12111","article-title":"Men and women, so different, so similar: observations from cross-sex hormone treatment of transsexual subjects","volume":"46","author":"Gooren","year":"2014","journal-title":"Andrologia"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2009.03632.x","article-title":"Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses","volume":"72","author":"Elamin","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"key\n\t\t\t\t2019011223580541100_B128","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.fertnstert.2010.03.048","article-title":"The impact of testosterone administration to female-to-male transsexuals on insulin resistance and lipid parameters compared with women with polycystic ovary syndrome","volume":"94","author":"Cupisti","year":"2010","journal-title":"Fertil Steril"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B129","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1745-7262.2006.00204.x","article-title":"Testosterone decreases adiponectin levels in female to male transsexuals","volume":"8","author":"Berra","year":"2006","journal-title":"Asian J Androl"},{"issue":"10","key":"key\n\t\t\t\t2019011223580541100_B130","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1111\/j.1743-6109.2012.02876.x","article-title":"Long-term evaluation of cross-sex hormone treatment in transsexual persons","volume":"9","author":"Wierckx","year":"2012","journal-title":"J Sex Med"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B131","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jpsychores.2015.02.001","article-title":"Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: a 2 year follow-up study","volume":"78","author":"Colizzi","year":"2015","journal-title":"J Psychosom Res"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B132","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MED.0000000000000202","article-title":"Bone in trans persons","volume":"22","author":"Van Caenegem","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"key\n\t\t\t\t2019011223580541100_B133","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.yhbeh.2007.05.012","article-title":"Cross-sex pattern of bone mineral density in early onset gender identity disorder","volume":"52","author":"Haraldsen","year":"2007","journal-title":"Horm Behav"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B134","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00774-011-0342-0","article-title":"A study of changes in bone metabolism in cases of gender identity disorder","volume":"30","author":"Miyajima","year":"2012","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-5122(96)01073-0","article-title":"Effects of hormone deficiency, androgen therapy and calcium supplementation on bone mineral density in female transsexuals","volume":"26","author":"Goh","year":"1997","journal-title":"Maturitas"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B136","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2265.2004.02125.x","article-title":"Testosterone increases bone mineral density in female-to-male transsexuals: a case series of 15 subjects","volume":"61","author":"Turner","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"key\n\t\t\t\t2019011223580541100_B137","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/j.1743-6109.2008.00909.x","article-title":"Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals","volume":"5","author":"Meriggiola","year":"2008","journal-title":"J Sex Med"},{"issue":"3","key":"key\n\t\t\t\t2019011223580541100_B138","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2265.1998.00396.x","article-title":"Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones","volume":"48","author":"van Kesteren","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"key\n\t\t\t\t2019011223580541100_B139","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00198-004-1754-7","article-title":"Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study","volume":"16","author":"Ruetsche","year":"2005","journal-title":"Osteoporos Int"},{"issue":"7","key":"key\n\t\t\t\t2019011223580541100_B140","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1210\/jc.2012-1187","article-title":"Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy","volume":"97","author":"Van Caenegem","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B141","first-page":"365","article-title":"Transsexualism and osteoporosis","volume":"106","author":"Schlatterer","year":"1998","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"11","key":"key\n\t\t\t\t2019011223580541100_B142","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/jbmr.5650111121","article-title":"The effect of androgen treatment on bone metabolism in female-to-male transsexuals","volume":"11","author":"Lips","year":"1996","journal-title":"J Bone Miner Res"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B143","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/ar.a.10119","article-title":"Bone\u2019s mechanostat: a 2003 update","volume":"275","author":"Frost","year":"2003","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B144","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/epirev\/mxw003","article-title":"Cancer in transgender people: evidence and methodological considerations","volume":"39","author":"Braun","year":"2017","journal-title":"Epidemiol Rev"},{"issue":"9","key":"key\n\t\t\t\t2019011223580541100_B145","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0026-0495(89)90233-3","article-title":"Mortality and morbidity in transsexual patients with cross-gender hormone treatment","volume":"38","author":"Asscheman","year":"1989","journal-title":"Metabolism"},{"issue":"3","key":"key\n\t\t\t\t2019011223580541100_B146","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones","volume":"47","author":"van Kesteren","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B147","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/humrep\/der406","article-title":"Reproductive wish in transsexual men","volume":"27","author":"Wierckx","year":"2012","journal-title":"Hum Reprod"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B148","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/09540261.2015.1084275","article-title":"Fertility options in transgender people","volume":"28","author":"De Roo","year":"2016","journal-title":"Int Rev Psychiatry"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B149","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.fertnstert.2015.02.003","article-title":"Antim\u00fcllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy","volume":"103","author":"Caanen","year":"2015","journal-title":"Fertil Steril"},{"issue":"6","key":"key\n\t\t\t\t2019011223580541100_B150","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.rbmo.2017.03.008","article-title":"Ovarian tissue cryopreservation in female-to-male transgender people: insights into ovarian histology and physiology after prolonged androgen treatment","volume":"34","author":"De Roo","year":"2017","journal-title":"Reprod Biomed Online"},{"issue":"11","key":"key\n\t\t\t\t2019011223580541100_B151","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s10815-017-0976-5","article-title":"Fertility preservation for trans men: frozen-thawed in vitro matured oocytes collected at the time of ovarian tissue processing exhibit normal meiotic spindles","volume":"34","author":"Lierman","year":"2017","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B152","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1753495X15612658","article-title":"Transgender men and pregnancy","volume":"9","author":"Obedin-Maliver","year":"2016","journal-title":"Obstet Med"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B153","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s007870050073","article-title":"Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent","volume":"7","author":"Cohen-Kettenis","year":"1998","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B154","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1210\/jcem-52-2-370","article-title":"Therapeutic use of pituitary desensitization with a long-acting LHRH agonist: a potential new treatment for idiopathic precocious puberty","volume":"52","author":"Crowley","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"issue":"8253","key":"key\n\t\t\t\t2019011223580541100_B155","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(81)91155-7","article-title":"D-TRP5-analogue of luteinising hormone releasing hormone in combination with cyproterone acetate to treat precocious puberty","volume":"2","author":"Laron","year":"1981","journal-title":"Lancet"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B156","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1542\/peds.2008-1783","article-title":"Consensus statement on the use of gonadotropin-releasing hormone analogs in children","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics"},{"issue":"7","key":"key\n\t\t\t\t2019011223580541100_B157","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jsxm.2016.05.004","article-title":"Efficacy and safety of gonadotropin-releasing hormone agonist treatment to suppress puberty in gender dysphoric adolescents","volume":"13","author":"Schagen","year":"2016","journal-title":"J Sex Med"},{"key":"key\n\t\t\t\t2019011223580541100_B158","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1530\/eje.1.02231","article-title":"Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects","volume":"155","author":"Delemarre-van de Waal","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019011223580541100_B159","doi-asserted-by":"crossref","first-page":"8","DOI":"10.15406\/emij.2015.02.00008","article-title":"Arterial hypertension as a complication of triptorelin treatment in adolescents with gender dysphoria","volume":"2","author":"Klink","year":"2015","journal-title":"Endocrinol Metab Int J"},{"issue":"10","key":"key\n\t\t\t\t2019011223580541100_B160","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s12098-012-0898-2","article-title":"Hypertension during therapy with triptorelin in a girl with precocious puberty","volume":"80","author":"Calcaterra","year":"2013","journal-title":"Indian J Pediatr"},{"issue":"9","key":"key\n\t\t\t\t2019011223580541100_B161","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00467-014-2795-6","article-title":"Arterial hypertension during treatment with triptorelin in a child with Williams-Beuren syndrome","volume":"29","author":"Siomou","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"key\n\t\t\t\t2019011223580541100_B162","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jsxm.2017.03.251","article-title":"Consecutive cyproterone acetate and estradiol treatment in late-pubertal transgender female adolescents","volume":"14","author":"Tack","year":"2017","journal-title":"J Sex Med"},{"issue":"1","key":"key\n\t\t\t\t2019011223580541100_B163","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13293-016-0067-9","article-title":"Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis","volume":"7","author":"Tack","year":"2016","journal-title":"Biol Sex Differ"},{"issue":"7","key":"key\n\t\t\t\t2019011223580541100_B164","first-page":"2356","article-title":"Efficacy and safety of pubertal induction using 17\u03b2-estradiol in transgirls","volume":"102","author":"Hannema","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key\n\t\t\t\t2019011223580541100_B165","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/jbmr.95","article-title":"Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis","volume":"25","author":"Berger","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B166","first-page":"216","article-title":"Normative data for lumbar spine bone mineral content in children: influence of age, height, weight, and pubertal stage","volume":"32","author":"De Schepper","year":"1991","journal-title":"J Nucl Med"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B167","doi-asserted-by":"crossref","first-page":"E270","DOI":"10.1210\/jc.2014-2439","article-title":"Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria","volume":"100","author":"Klink","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019011223580541100_B168","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2016.11.008","article-title":"Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents","volume":"95","author":"Vlot","year":"2017","journal-title":"Bone"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B169","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10508-011-9758-9","article-title":"Puberty suppression in a gender-dysphoric adolescent: a 22-year follow-up","volume":"40","author":"Cohen-Kettenis","year":"2011","journal-title":"Arch Sex Behav"},{"issue":"3","key":"key\n\t\t\t\t2019011223580541100_B170","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.beem.2015.01.004","article-title":"Adolescents with gender dysphoria","volume":"29","author":"Cohen-Kettenis","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"key\n\t\t\t\t2019011223580541100_B171","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1111\/j.1743-6109.2010.01943.x","article-title":"Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study","volume":"8","author":"de Vries","year":"2011","journal-title":"J Sex Med"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B172","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1542\/peds.2013-2958","article-title":"Young adult psychological outcome after puberty suppression and gender reassignment","volume":"134","author":"de Vries","year":"2014","journal-title":"Pediatrics"},{"issue":"4","key":"key\n\t\t\t\t2019011223580541100_B173","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1210\/jc.2016-3007","article-title":"Transgender health in endocrinology: current status of endocrinology fellowship programs and practicing clinicians","volume":"102","author":"Davidge-Pitts","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t2019011223580541100_B174","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MED.0000000000000231","article-title":"Priorities for transgender medical and healthcare research","volume":"23","author":"Feldman","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/40\/1\/97\/27498717\/er.2018-00011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:24:57Z","timestamp":1775244297000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/40\/1\/97\/5123979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":174,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,10,10]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2018-00011","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,10,10]]}}}